SavedAdd your journal

Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2006 / Cilt: 40 - Sayı: 3

The effect on quality of life of narrowband UVB therapy for patients with chronic plaque psoriasis

Kronik plak psoriazis hastalarında darbant UVB tedavisinin yaşam kalitesi üzerine etkileri

Adem KÖŞLÜ
Gonca GÖKDEMİR
Neslihan FİŞEK
Pages
90–93
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Disease severity and quality of life significantly improved after therapy (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Patients with psoriasis have significant impairment in their quality of life.
📊
Key Findings & Data:MATERIALS-METHODS: A total of 37 patients with chronic plaque psoriasis were recruited to study between October 2004-May 2005.
💡
Conclusion & Impact:Disease severity and quality of life significantly improved after therapy (p
🔬Design:Survey & Empirical Study
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Patients with psoriasis have significant impairment in their quality of life. As there is no cure for psoriasis, there are many treatment options. Narrowband UVB therapy have many advantages and therapeutic effects. So, narrowband UVB therapy for psoriasis is a popular treatment model recently. In literature, there are few data about the effect of quality of life with treatment of narrowband UVB. Our aim is to assess the relationship between changes in quality of life and severity of psoriasis after narrowband UVB therapy. MATERIALS-METHODS: A total of 37 patients with chronic plaque psoriasis were recruited to study between October 2004-May 2005. All of the patients were allocated to three times weekly treatment with narrowband UVB. All patients were assessed using psoriasis area severity index (PASI) and dermatology life quality index (DLQI) before and after treatment. All patients were asked to complete “self assessment form” questionnaire after therapy. RESULTS: Only 26 patients (70.3%) completed therapy. Disease severity and quality of life significantly improved after therapy (p

Özet

Giriş ve AMAÇ: Psöriazis, hastaların yaşam kalitesini önemli ölçüde etkileyen bir hastalıktır. Hastalıkta tam kür olmadığı için pek çok tedavi alternatifleri mevcuttur. Darbant ultraviyole B (UVB) tedavisi, avantajları ve klinik etkinliği nedeniyle son yıllarda popüler bir tedavi alternatifi olmuştur. Yerli ve yabancı literatürde bu tedavinin psoriazisli hastalardaki yaşam kalitesi üzerine etkileri ile ilgili çok az çalışma bulunmaktadır. Bu çalışmanın amacı, darbant ultraviyole B tedavisinin psoriazis hastalarındaki yaşam kalitesini nasıl etkilediğini araştırmaktı. GEREÇ-YÖNTEM: Çalışmaya Ekim 2004-Mayıs 2005 tarihleri arasında toplam 37 kronik plak psoriazis hastası alındı. Hastalara haftada 3 gün olmak üzere darbant UVB tedavisi uygulandı. Tedavi öncesi ve sonrasında PAŞİ değerleri ölçüldü, “Dermatoloji yaşam kalitesi indeksi”(DYKİ) anketi uygulandı. Tedavi sonunda her hastaya “kendilerini değerlendirme anketi” dolduruldu. Çalışmaya alınan 37 hastadan 26'sı (%70.3) tedaviyi tamamladı. SONUÇ: Çalışmanın başında ve sonunda saptanan PAŞİ ve DYKİ skorları arasındaki fark istatistiksel olarak anlamlı bulundu (p

🔖

Cite This Article

KÖŞLÜ, A., GÖKDEMİR, G., FİŞEK, N. (2022). The effect on quality of life of narrowband UVB therapy for patients with chronic plaque psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 40 - Sayı: 3, 90–93. https://ajindex.com/articles/622182

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ: Determinants of quality in patients with psoriasis: A study from the US population. J Am Acad Dermatol 2004; 51:704-8
  2. Zaghloul SS, Goodfield MJD: Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140:408-414
  3. Katugampola RP, Hongbo Y, Finlay AY: Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. Br J Dermatol 2005;152:1256-1262
  4. Touw CR, Hakkaatr-Van Roijen L, Verboom P, Paul C, Rutten FFH, Finlay AY: Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-972
  5. Finlay AY, Khan GK: Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994,19:210-216
  6. Loo WJ, Diba V, Chawla M, Finlay AY: Dermatology life quality index: influence of an illustrated version. Br J Dermatol 2003; 148:279-284
  7. Kaufman KD, Olsen EA, Whiting D, Savin R et al: Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998; 39:578-89
  8. Feldman SR, Koo JYM, Menter A, Bagel J: Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol 2005;53:101-7
  9. Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D: Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 2003; 149:318-322
  10. SampognaF, Sera F, Abeni D: Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: A cluster analysis. J Invest Dermatol 2004; 122:602-607
  11. Aciöz E, Gökdemir G, Köşlü A: Dermatolojide yaşam kalitesi. Türkderm 2003;37:16-23
  12. McKenna SP, Lebwohl M, Kahler KN: Development of the US PSORIQoL: a psoriasis-specific measure of quality of life. Int J Dermatol 2005;44:462-469
  13. İnanır I, Aydemir Ö, Gündüz K, Danacı AE, Ermertcan AT: Psoriasisli hastalarda yaşam kalite ölçeği geliştirilmesi. Türkderm 2003;37:189-195
  14. Gupta G, Long J, Tillman DM: The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures.'Br J Dermatol 1999; 140:887-890
  15. Lebwohl M: A clinician's:paradigm in the treatment of psoriasis. J Am Acad Dermatol 2005;53:S59-69
  16. Vensel E, Hilley T, Trent J, Taylor JR, Kirsner RS, Kerdel FA, Taylor JR, Schwartzberg JB: Sustained improvement of the quality of life of patients with